Olema Pharmaceuticals【OLMA】株式ニュース

名称	銘柄コード	市場	種別
Olema Pharmaceuticals Inc	OLMA	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.31	2.61%	12.18	07:29:50

始値	安値	高値	終値	前日終値
11.78	11.55	12.16	12.00	11.87

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/19	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/19	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/19	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/19	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/15	05:39	EDGAR2	Form 8-K - Current report
2024/6/07	07:49	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2024/6/07	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/06	23:05	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/06	23:02	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/05	10:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/05	05:28	GLOBE	Olema Oncology Reports Inducement Grants Under Nasdaq..
2024/6/05	04:09	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/04	03:55	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/01	01:17	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/29	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/28	20:03	GLOBE	Olema Oncology to Participate in Upcoming Investor..
2024/5/15	20:06	EDGAR2	Form 8-K - Current report
2024/5/15	20:01	GLOBE	Olema Oncology Announces Promising New Data for Palazestrant..
2024/5/09	05:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	05:06	EDGAR2	Form 8-K - Current report
2024/5/09	05:02	GLOBE	Olema Oncology Reports First Quarter 2024 Financial Results..
2024/5/08	20:02	GLOBE	Olema Oncology Announces New Clinical Data for Palazestrant..
2024/5/08	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/07	05:00	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/03	05:37	GLOBE	Olema Oncology Reports Inducement Grants Under Nasdaq..
2024/5/01	20:02	GLOBE	Olema Oncology to Participate in Upcoming Investor..
2024/4/09	05:30	GLOBE	Olema Oncology to Participate in Canaccord Genuity 2024..
2024/4/03	05:29	GLOBE	Olema Oncology Reports Inducement Grants Under Nasdaq..
2024/3/12	05:31	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/3/12	05:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/12	05:05	EDGAR2	Form 8-K - Current report
2024/3/12	05:03	GLOBE	Olema Oncology Reports Fourth Quarter and Full-Year 2023..
2024/3/06	21:03	GLOBE	Olema Oncology Announces Publication of Data Highlighting..
2024/3/05	07:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	06:30	GLOBE	Olema Oncology Reports Inducement Grants Under Nasdaq..
2024/3/01	04:26	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/15	06:08	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	02:53	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/13	07:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/12	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/2/06	21:01	GLOBE	Olema Oncology to Participate in Upcoming Investor..
2024/2/06	07:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	07:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	07:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:30	GLOBE	Olema Oncology Reports Inducement Grants Under Nasdaq..
2024/2/02	05:24	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/01	06:21	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/2/01	04:58	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/29	21:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..